rs11076805 - ADCY9

Magnitude 2.2 · 1 study on file

Reported associations

  • Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer - Unknown journal (n.d.) · Unknown authors · PubMed 29058716

    ABSTRACT: Most common breast cancer susceptibility variants have been identified through genome-wide association studies (GWAS) of predominantly estrogen receptor (ER)-positive disease. We conducted a GWAS using 21,468 ER-negative cases and 100,594 controls combined with 18,908 BRCA1 mutation carriers (9,414 with breast cancer), all of European origin. We identified independent associations at P < 5 × 10−8 with ten variants at nine new loci. At P < 0.05, we replicated associations with 10 of 11 variants previously reported in ER-negative disease or BRCA1 mutation carrier GWAS and observed consistent associations with ER-negative disease for 105 susceptibility variants identified by other studies. These 125 variants explain approximately 14% of the familial risk of this breast cancer sub


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Screening

  • breast cancer screening strategy Moderate

    rs11076805-C is associated with increased breast cancer risk, suggesting benefit of screening discussion

    Discuss with healthcare provider about genetic risk and optimal screening age